How successful is corneal transplantation? A report from the Australian Corneal Graft Register
- PMID: 7556721
- DOI: 10.1038/eye.1995.43
How successful is corneal transplantation? A report from the Australian Corneal Graft Register
Abstract
Corneal graft outcome was assessed within a large, prospectively collected database of 4499 records. Penetrating corneal graft survival was 91% at 1 year, 72% at 5 years and 69% at 7 years. The three most common indications for graft were keratoconus (30%), bullous keratopathy (25%) and failed previous graft (18%); the three most common causes of graft failure were rejection (34%), infection (18%) and glaucoma (9%). The vast majority of grafts were performed for improved visual acuity. About four-fifths of recipients achieved at least one line of better acuity on the Snellen chart post-operatively; of the remainder with unchanged or worse acuity, only 21% had failed grafts. Overall, 43% of recipients achieved a best corrected Snellen acuity of 6/12 or better, 52% achieved 6/18 or better, and 20% had acuitities of less than 6/60. Reasons for poor post-operative acuity (recorded as less than 6/60) included graft failure (41%) and comorbidities in the grafted eye (43%). A number of risk factors for graft failure were examined: in most instances, there was little room for decision-making or expert intervention.
Similar articles
-
Risk factors for human corneal graft failure within the Australian corneal graft registry.Transplantation. 2008 Dec 27;86(12):1720-4. doi: 10.1097/TP.0b013e3181903b0a. Transplantation. 2008. PMID: 19104411
-
The Australian Corneal Graft Registry. 1990 to 1992 report.Aust N Z J Ophthalmol. 1993 May;21(2 Suppl):1-48. Aust N Z J Ophthalmol. 1993. PMID: 8333942 Review.
-
Corneal transplantation for keratoconus: a registry study.Arch Ophthalmol. 2011 Jun;129(6):691-7. doi: 10.1001/archophthalmol.2011.7. Epub 2011 Feb 14. Arch Ophthalmol. 2011. PMID: 21320951
-
Large-diameter penetrating keratoplasty: indications and outcomes.Cornea. 2010 Mar;29(3):296-301. doi: 10.1097/ICO.0b013e3181b6489e. Cornea. 2010. PMID: 20118782
-
Outcomes of corneal transplantation in Europe: report by the European Cornea and Cell Transplantation Registry.J Cataract Refract Surg. 2021 Jun 1;47(6):780-785. doi: 10.1097/j.jcrs.0000000000000520. J Cataract Refract Surg. 2021. PMID: 33278237 Review.
Cited by
-
Strategies for local gene therapy of corneal allograft rejection.Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):11-25. doi: 10.4103/0974-9233.106382. Middle East Afr J Ophthalmol. 2013. PMID: 23580848 Free PMC article. Review.
-
Incidence of Complications Related to Corneal Graft in a Group of 758 Patients.J Clin Med. 2022 Dec 28;12(1):220. doi: 10.3390/jcm12010220. J Clin Med. 2022. PMID: 36615021 Free PMC article.
-
In vitro adenovirus mediated gene transfer to the human cornea.Br J Ophthalmol. 2005 Jun;89(6):658-61. doi: 10.1136/bjo.2004.061754. Br J Ophthalmol. 2005. PMID: 15923495 Free PMC article.
-
Local and Systemic Injections of Human Cord Blood Myeloid-Derived Suppressor Cells to Prevent Graft Rejection in Corneal Transplantation.Biomedicines. 2022 Dec 12;10(12):3223. doi: 10.3390/biomedicines10123223. Biomedicines. 2022. PMID: 36551981 Free PMC article.
-
The purinergic receptor antagonist oxidized adenosine triphosphate suppresses immune-mediated corneal allograft rejection.Sci Rep. 2019 Jun 13;9(1):8617. doi: 10.1038/s41598-019-44973-y. Sci Rep. 2019. PMID: 31197223 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources